Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
AMWL 
American Well Corp (AMWL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: AMWL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $10.33
1 Year Target Price $10.33
| 1 | Strong Buy |
| 0 | Buy |
| 8 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -65.43% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 125.53M USD | Price to earnings Ratio - | 1Y Target Price 10.33 |
Price to earnings Ratio - | 1Y Target Price 10.33 | ||
Volume (30-day avg) 9 | Beta 1.19 | 52 Weeks Range 5.20 - 12.95 | Updated Date 06/30/2025 |
52 Weeks Range 5.20 - 12.95 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -10.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -59.13% | Operating Margin (TTM) -40.32% |
Management Effectiveness
Return on Assets (TTM) -20.31% | Return on Equity (TTM) -43.21% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -89586746 | Price to Sales(TTM) 0.48 |
Enterprise Value -89586746 | Price to Sales(TTM) 0.48 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA -0.82 | Shares Outstanding 14162300 | Shares Floating 12024627 |
Shares Outstanding 14162300 | Shares Floating 12024627 | ||
Percent Insiders 5.35 | Percent Institutions 46.84 |
Analyst Ratings
Rating 3 | Target Price 10.33 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 8 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Well Corp
Company Overview
History and Background
American Well Corp, now known as Amwell, was founded in 2006. It pioneered telehealth services, initially focusing on connecting patients with doctors via video consultations. Over time, it expanded its offerings to include a broader range of digital healthcare solutions.
Core Business Areas
- Amwell Platform: Provides a technology platform for healthcare providers and organizations to offer telehealth services, including video visits, secure messaging, and remote monitoring.
- Amwell Medical Group: Offers direct-to-consumer telehealth services through its own network of physicians and other healthcare professionals.
Leadership and Structure
The leadership team consists of executives overseeing technology, operations, finance, and clinical services. The organizational structure includes departments for engineering, product development, sales, marketing, and customer support.
Top Products and Market Share
Key Offerings
- Amwell Platform: A comprehensive telehealth platform used by hospitals, health systems, and payers. While specific market share data is challenging to pinpoint, Amwell is considered a major player in the telehealth platform market. Competitors include Teladoc Health, Veeva Systems, and Cerner.
- Amwell Medical Group: Provides on-demand virtual care services directly to patients. Revenue figures are not publicly broken down by product. Competitors include Teladoc Health, MDLIVE, and Doctor On Demand.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth, driven by increasing demand for remote healthcare services, technological advancements, and favorable regulatory changes. The industry is becoming increasingly competitive.
Positioning
Amwell is positioned as a leading telehealth platform provider and virtual care delivery company. Its competitive advantages include its established platform, extensive network of providers, and strong brand recognition.
Total Addressable Market (TAM)
The telehealth market is projected to reach hundreds of billions of dollars in the coming years. Amwell is positioned to capture a portion of this market by expanding its platform offerings and growing its customer base.
Upturn SWOT Analysis
Strengths
- Established platform
- Strong brand recognition
- Extensive provider network
- Experience in telehealth market
Weaknesses
- Historical Losses and Path to Profitability
- Intense competition
- Customer retention is vital for long term sustainability
- Cost of technology development
- Need for continual innovation.
Opportunities
- Growing demand for telehealth
- Expansion into new markets
- Partnerships with healthcare providers and payers
- Adoption of new technologies (e.g., AI)
- Government support for telehealth
Threats
- Increasing competition
- Regulatory changes
- Reimbursement challenges
- Data security risks
- Economic Slowdown
Competitors and Market Share
Key Competitors
- TDOC
- LVGO
- ONEM
Competitive Landscape
Amwell competes with other telehealth providers based on platform capabilities, provider network, pricing, and customer service.
Major Acquisitions
SilverCloud Health
- Year: 2021
- Acquisition Price (USD millions): 250
- Strategic Rationale: Expanded Amwell's behavioral health offerings and enhanced its ability to provide personalized care.
Growth Trajectory and Initiatives
Historical Growth: Growth trends will be represented in future updates
Future Projections: Future growth projections will be provided in future updates
Recent Initiatives: Recent initiatives will be added in future updates
Summary
Amwell is a significant player in the growing telehealth market with an established platform. While it faces strong competition and needs to achieve profitability, its strategic acquisitions and expanding market create growth opportunities. Monitoring regulatory changes and maintaining technological leadership are key for Amwell's success. The company needs to demonstrate financial stability to reassure investors about long term viability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market conditions and company performance can change rapidly. This is based on the best publicly available information
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Well Corp
Exchange NYSE | Headquaters Boston, MA, United States | ||
IPO Launch date 2020-09-17 | Chairman & CEO Dr. Ido Schoenberg M.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 877 | Website https://business.amwell.com |
Full time employees 877 | Website https://business.amwell.com | ||
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.